<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://ecoliwiki.org/colipedia/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=165.91.15.120</id>
	<title>EcoliWiki - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://ecoliwiki.org/colipedia/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=165.91.15.120"/>
	<link rel="alternate" type="text/html" href="https://ecoliwiki.org/colipedia/index.php/Special:Contributions/165.91.15.120"/>
	<updated>2026-11-19T15:26:41Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.11</generator>
	<entry>
		<id>https://ecoliwiki.org/colipedia/index.php?title=PMID:18250190&amp;diff=1078376</id>
		<title>PMID:18250190</title>
		<link rel="alternate" type="text/html" href="https://ecoliwiki.org/colipedia/index.php?title=PMID:18250190&amp;diff=1078376"/>
		<updated>2010-04-07T21:57:26Z</updated>

		<summary type="html">&lt;p&gt;165.91.15.120: Fill PMID: Page!&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{RightTOC}}&lt;br /&gt;
&amp;lt;protect&amp;gt;&lt;br /&gt;
&amp;lt;span style = &#039;font-size: large&#039;&amp;gt; &#039;&#039;&#039;Davies, TA, Shang, W, Bush, K and Flamm, RK&#039;&#039;&#039;  (2008) Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa.&#039;&#039;Antimicrob. Agents Chemother.&#039;&#039; &#039;&#039;&#039;52&#039;&#039;&#039;:1510-2&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|{{Prettytable}} align = &#039;center&#039; width= &#039;70%&#039;&lt;br /&gt;
|-&lt;br /&gt;
|{{TableHeadingColor}} |&#039;&#039;&#039;Abstract&#039;&#039;&#039; || &amp;lt;protect&amp;gt;Doripenem, a parenteral carbapenem, exhibited high affinity for penicillin-binding protein 2 (PBP2) and PBP3 in Pseudomonas aeruginosa and PBP2 in Escherichia coli, the primary PBPs whose inhibition leads to cell death. This PBP affinity profile correlates with the broad-spectrum gram-negative activity observed with doripenem.&amp;lt;/protect&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|{{TableHeadingColor}} nowrap |&#039;&#039;&#039;Links&#039;&#039;&#039; ||  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=pubmed&amp;amp;dopt=Abstract&amp;amp;list_uids=18250190 PubMed]&amp;lt;br/&amp;gt;Online version:[http://dx.doi.org/10.1128/AAC.01529-07 10.1128/AAC.01529-07]&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;/protect&amp;gt;&lt;br /&gt;
==Significance {{HelpIcon|Help:Literature}} ==&lt;br /&gt;
{{LitSignificance}}&lt;br /&gt;
&lt;br /&gt;
== Useful Materials and Methods {{HelpIcon|Help:Literature}}==&lt;br /&gt;
{{LitMaterials}}&lt;br /&gt;
&lt;br /&gt;
==Annotations {{HelpIcon|Help:Literature}}==&lt;br /&gt;
&amp;lt;protect&amp;gt;&amp;lt;!--box uid=63ce1649aab8b3180235b0af7618f667.171739.J4bbcffc6500d5--&amp;gt;&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
******************************************************************************************&lt;br /&gt;
* &lt;br /&gt;
*   ** PLEASE DON&#039;T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. ** &lt;br /&gt;
* &lt;br /&gt;
****************************************************************************************** --&amp;gt;&lt;br /&gt;
{|   id=&amp;quot;J4bbcffc6500d5&amp;quot;  class=&amp;quot; tableEdit GO_table_reference&amp;quot;  &lt;br /&gt;
|- {{table heading style}}&lt;br /&gt;
!|Gene product!!Qualifier!!GO ID!!GO term name!!Evidence Code!!with/from!!Aspect!!Notes!!Status&lt;br /&gt;
&lt;br /&gt;
|- class=&amp;quot;tableEdit_footer&amp;quot; &lt;br /&gt;
|&amp;lt;span class=&amp;quot;tableEdit_editLink plainlinks&amp;quot;&amp;gt;[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&amp;amp;id=63ce1649aab8b3180235b0af7618f667.171739.J4bbcffc6500d5&amp;amp;page=171739&amp;amp;pagename={{FULLPAGENAMEE}}&amp;amp;type=0&amp;amp;template=GO_table_reference edit table]&amp;lt;/span&amp;gt; || || || || || || || ||&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;!--box uid=63ce1649aab8b3180235b0af7618f667.171739.J4bbcffc6500d5--&amp;gt;&amp;lt;/protect&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==EcoliWiki Links {{HelpIcon|Help:Literature}} ==&lt;br /&gt;
{{LitLinks}}&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{RefHelp}}&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>165.91.15.120</name></author>
	</entry>
	<entry>
		<id>https://ecoliwiki.org/colipedia/index.php?title=PMID:18250190&amp;diff=1078375</id>
		<title>PMID:18250190</title>
		<link rel="alternate" type="text/html" href="https://ecoliwiki.org/colipedia/index.php?title=PMID:18250190&amp;diff=1078375"/>
		<updated>2010-04-07T21:57:26Z</updated>

		<summary type="html">&lt;p&gt;165.91.15.120: New PMID: Page!&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>165.91.15.120</name></author>
	</entry>
	<entry>
		<id>https://ecoliwiki.org/colipedia/index.php?title=PMID:17470659&amp;diff=1078374</id>
		<title>PMID:17470659</title>
		<link rel="alternate" type="text/html" href="https://ecoliwiki.org/colipedia/index.php?title=PMID:17470659&amp;diff=1078374"/>
		<updated>2010-04-07T21:57:18Z</updated>

		<summary type="html">&lt;p&gt;165.91.15.120: Fill PMID: Page!&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{RightTOC}}&lt;br /&gt;
&amp;lt;protect&amp;gt;&lt;br /&gt;
&amp;lt;span style = &#039;font-size: large&#039;&amp;gt; &#039;&#039;&#039;Davies, TA, Page, MG, Shang, W, Andrew, T, Kania, M and Bush, K&#039;&#039;&#039;  (2007) Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae.&#039;&#039;Antimicrob. Agents Chemother.&#039;&#039; &#039;&#039;&#039;51&#039;&#039;&#039;:2621-4&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|{{Prettytable}} align = &#039;center&#039; width= &#039;70%&#039;&lt;br /&gt;
|-&lt;br /&gt;
|{{TableHeadingColor}} |&#039;&#039;&#039;Abstract&#039;&#039;&#039; || &amp;lt;protect&amp;gt;Ceftobiprole exhibited tight binding to PBP2a in methicillin-resistant Staphylococcus aureus, PBP2x in penicillin-resistant Streptococcus pneumoniae, and PBP3 and other essential penicillin-binding proteins in methicillin-susceptible S. aureus, Escherichia coli, and Pseudomonas aeruginosa. Ceftobiprole also bound well to PBP2 in the latter organisms, contributing to the broad-spectrum antibacterial activity against gram-negative and gram-positive bacteria.&amp;lt;/protect&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|{{TableHeadingColor}} nowrap |&#039;&#039;&#039;Links&#039;&#039;&#039; ||  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=pubmed&amp;amp;dopt=Abstract&amp;amp;list_uids=17470659 PubMed]&amp;lt;br/&amp;gt;Online version:[http://dx.doi.org/10.1128/AAC.00029-07 10.1128/AAC.00029-07]&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;/protect&amp;gt;&lt;br /&gt;
==Significance {{HelpIcon|Help:Literature}} ==&lt;br /&gt;
{{LitSignificance}}&lt;br /&gt;
&lt;br /&gt;
== Useful Materials and Methods {{HelpIcon|Help:Literature}}==&lt;br /&gt;
{{LitMaterials}}&lt;br /&gt;
&lt;br /&gt;
==Annotations {{HelpIcon|Help:Literature}}==&lt;br /&gt;
&amp;lt;protect&amp;gt;&amp;lt;!--box uid=63ce1649aab8b3180235b0af7618f667.171738.A4bbcffbe46d8e--&amp;gt;&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
******************************************************************************************&lt;br /&gt;
* &lt;br /&gt;
*   ** PLEASE DON&#039;T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. ** &lt;br /&gt;
* &lt;br /&gt;
****************************************************************************************** --&amp;gt;&lt;br /&gt;
{|   id=&amp;quot;A4bbcffbe46d8e&amp;quot;  class=&amp;quot; tableEdit GO_table_reference&amp;quot;  &lt;br /&gt;
|- {{table heading style}}&lt;br /&gt;
!|Gene product!!Qualifier!!GO ID!!GO term name!!Evidence Code!!with/from!!Aspect!!Notes!!Status&lt;br /&gt;
&lt;br /&gt;
|- class=&amp;quot;tableEdit_footer&amp;quot; &lt;br /&gt;
|&amp;lt;span class=&amp;quot;tableEdit_editLink plainlinks&amp;quot;&amp;gt;[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&amp;amp;id=63ce1649aab8b3180235b0af7618f667.171738.A4bbcffbe46d8e&amp;amp;page=171738&amp;amp;pagename={{FULLPAGENAMEE}}&amp;amp;type=0&amp;amp;template=GO_table_reference edit table]&amp;lt;/span&amp;gt; || || || || || || || ||&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;!--box uid=63ce1649aab8b3180235b0af7618f667.171738.A4bbcffbe46d8e--&amp;gt;&amp;lt;/protect&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==EcoliWiki Links {{HelpIcon|Help:Literature}} ==&lt;br /&gt;
{{LitLinks}}&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{RefHelp}}&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>165.91.15.120</name></author>
	</entry>
	<entry>
		<id>https://ecoliwiki.org/colipedia/index.php?title=PMID:17470659&amp;diff=1078373</id>
		<title>PMID:17470659</title>
		<link rel="alternate" type="text/html" href="https://ecoliwiki.org/colipedia/index.php?title=PMID:17470659&amp;diff=1078373"/>
		<updated>2010-04-07T21:57:18Z</updated>

		<summary type="html">&lt;p&gt;165.91.15.120: New PMID: Page!&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>165.91.15.120</name></author>
	</entry>
	<entry>
		<id>https://ecoliwiki.org/colipedia/index.php?title=PMID:12886052&amp;diff=1078372</id>
		<title>PMID:12886052</title>
		<link rel="alternate" type="text/html" href="https://ecoliwiki.org/colipedia/index.php?title=PMID:12886052&amp;diff=1078372"/>
		<updated>2010-04-07T21:57:08Z</updated>

		<summary type="html">&lt;p&gt;165.91.15.120: Fill PMID: Page!&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{RightTOC}}&lt;br /&gt;
&amp;lt;protect&amp;gt;&lt;br /&gt;
&amp;lt;span style = &#039;font-size: large&#039;&amp;gt; &#039;&#039;&#039;Dalhoff, A, Nasu, T and Okamoto, K&#039;&#039;&#039;  (2003) Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria.&#039;&#039;Chemotherapy&#039;&#039; &#039;&#039;&#039;49&#039;&#039;&#039;:172-83&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|{{Prettytable}} align = &#039;center&#039; width= &#039;70%&#039;&lt;br /&gt;
|-&lt;br /&gt;
|{{TableHeadingColor}} |&#039;&#039;&#039;Abstract&#039;&#039;&#039; || &amp;lt;protect&amp;gt;Faropenem is a new oral beta-lactam antibiotic unique from carbapenems and other available beta-lactams. Determinants of the in vitro activity of beta-lactam antibiotics include affinity to penicillin-binding proteins (PBPs) and beta-lactamase stability. In this study, the binding affinity of faropenem to various PBPs and its impact on the morphology of Staphylococcus aureus and Escherichia coli were evaluated. In general, faropenem demonstrated high binding affinity to high-molecular-weight PBPs but low affinity to low-molecular-weight PBPs. In S. aureus and Streptococcus pneumoniae, faropenem exhibited high binding affinity to PBP1, followed by PBP3 and PBP2. In E. coli, faropenem showed the highest affinity for PBP2, followed by PBP1A, PBP1B, PBP3 and PBP4. In Proteus vulgaris, binding was highest to PBP4, followed by PBP1A, PBP2 and PBP3. In Serratia marcescens, faropenem bound preferentially to PBP2 and PBP4. Exposure of S. aureus to faropenem at minimum inhibitory concentrations (MICs) of 1/8 or 1/4 resulted in irregular septum formation. At 1x MIC or higher, a larger number of lysed cells were observed. Exposure of E. coli to 1/8x MIC or 1/4x MIC also induced changes in cellular shape; the normal rod-shaped form changed to a spherical form in a time-dependent manner. After exposure of E. coli to 1x MIC for 2 h, bulging-shaped E. coli cells were observed and after 4 h of exposure cell lysis was demonstrated. In the presence of 4x MIC, spheroplast-like forms and cell lysis were observed. The morphological changes triggered by faropenem are in agreement with the PBP binding affinities reported. Thus, the high binding affinities of faropenem to PBPs from gram-negative and gram-positive bacteria are mirrored by its pronounced and concentration-dependent bactericidal effect.&amp;lt;/protect&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|{{TableHeadingColor}} nowrap |&#039;&#039;&#039;Links&#039;&#039;&#039; ||  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=pubmed&amp;amp;dopt=Abstract&amp;amp;list_uids=12886052 PubMed]&amp;lt;br/&amp;gt;Online version:[http://dx.doi.org/10.1159/000071141 10.1159/000071141]&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;/protect&amp;gt;&lt;br /&gt;
==Significance {{HelpIcon|Help:Literature}} ==&lt;br /&gt;
{{LitSignificance}}&lt;br /&gt;
&lt;br /&gt;
== Useful Materials and Methods {{HelpIcon|Help:Literature}}==&lt;br /&gt;
{{LitMaterials}}&lt;br /&gt;
&lt;br /&gt;
==Annotations {{HelpIcon|Help:Literature}}==&lt;br /&gt;
&amp;lt;protect&amp;gt;&amp;lt;!--box uid=63ce1649aab8b3180235b0af7618f667.171737.R4bbcffb4486f5--&amp;gt;&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
******************************************************************************************&lt;br /&gt;
* &lt;br /&gt;
*   ** PLEASE DON&#039;T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. ** &lt;br /&gt;
* &lt;br /&gt;
****************************************************************************************** --&amp;gt;&lt;br /&gt;
{|   id=&amp;quot;R4bbcffb4486f5&amp;quot;  class=&amp;quot; tableEdit GO_table_reference&amp;quot;  &lt;br /&gt;
|- {{table heading style}}&lt;br /&gt;
!|Gene product!!Qualifier!!GO ID!!GO term name!!Evidence Code!!with/from!!Aspect!!Notes!!Status&lt;br /&gt;
&lt;br /&gt;
|- class=&amp;quot;tableEdit_footer&amp;quot; &lt;br /&gt;
|&amp;lt;span class=&amp;quot;tableEdit_editLink plainlinks&amp;quot;&amp;gt;[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&amp;amp;id=63ce1649aab8b3180235b0af7618f667.171737.R4bbcffb4486f5&amp;amp;page=171737&amp;amp;pagename={{FULLPAGENAMEE}}&amp;amp;type=0&amp;amp;template=GO_table_reference edit table]&amp;lt;/span&amp;gt; || || || || || || || ||&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;!--box uid=63ce1649aab8b3180235b0af7618f667.171737.R4bbcffb4486f5--&amp;gt;&amp;lt;/protect&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==EcoliWiki Links {{HelpIcon|Help:Literature}} ==&lt;br /&gt;
{{LitLinks}}&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{RefHelp}}&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>165.91.15.120</name></author>
	</entry>
	<entry>
		<id>https://ecoliwiki.org/colipedia/index.php?title=PMID:12886052&amp;diff=1078371</id>
		<title>PMID:12886052</title>
		<link rel="alternate" type="text/html" href="https://ecoliwiki.org/colipedia/index.php?title=PMID:12886052&amp;diff=1078371"/>
		<updated>2010-04-07T21:57:08Z</updated>

		<summary type="html">&lt;p&gt;165.91.15.120: New PMID: Page!&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>165.91.15.120</name></author>
	</entry>
	<entry>
		<id>https://ecoliwiki.org/colipedia/index.php?title=PMID:12709336&amp;diff=1078370</id>
		<title>PMID:12709336</title>
		<link rel="alternate" type="text/html" href="https://ecoliwiki.org/colipedia/index.php?title=PMID:12709336&amp;diff=1078370"/>
		<updated>2010-04-07T21:56:54Z</updated>

		<summary type="html">&lt;p&gt;165.91.15.120: Fill PMID: Page!&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{RightTOC}}&lt;br /&gt;
&amp;lt;protect&amp;gt;&lt;br /&gt;
&amp;lt;span style = &#039;font-size: large&#039;&amp;gt; &#039;&#039;&#039;Jamieson, CE, Lambert, PA and Simpson, IN&#039;&#039;&#039;  (2003) In vitro and in vivo activities of AM-112, a novel oxapenem.&#039;&#039;Antimicrob. Agents Chemother.&#039;&#039; &#039;&#039;&#039;47&#039;&#039;&#039;:1652-7&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|{{Prettytable}} align = &#039;center&#039; width= &#039;70%&#039;&lt;br /&gt;
|-&lt;br /&gt;
|{{TableHeadingColor}} |&#039;&#039;&#039;Abstract&#039;&#039;&#039; || &amp;lt;protect&amp;gt;AM-112 [(1&#039;R,5R,6R)-3-(4-amino-1,1-dimethyl-butyl)-6-(1&#039;-hydroxyethyl)oxapenem-3-carboxylate] is a novel oxapenem compound which possesses potent beta-lactamase-inhibitory properties. Fifty-percent inhibitory concentrations (IC(50)s) of AM-112 for class A enzymes were between 0.16 and 2.24 micro M for three enzymes, compared to IC(50)s of 0.008 to 0.12 micro M for clavulanic acid. Against class C and class D enzymes, however, the activity of AM-112 was between 1,000- and 100,000-fold greater than that of clavulanic acid. AM-112 had affinity for the penicillin-binding proteins (PBPs) of Escherichia coli DC0, with PBP2 being inhibited by the lowest concentration of AM-112 tested, 0.1 micro g/ml. Ceftazidime was combined with AM-112 at 1:1 and 2:1 ratios in MIC determination studies against a panel of beta-lactamase-producing organisms. These studies demonstrated that AM-112 was effective at protecting ceftazidime against extended-spectrum beta-lactamase-producing strains and derepressed class C enzyme producers, reducing ceftazidime MICs by 16- and 2,048-fold. Similar results were obtained when AM-112 was combined with ceftriaxone, cefoperazone, or cefepime in a 1:2 ratio. Protection of ceftazidime with AM-112 was maintained against Enterobacter cloacae P99 and Klebsiella pneumoniae SHV-5 in a murine intraperitoneal sepsis model. The 50% effective dose of ceftazidime against E. cloacae P99 and K. pneumoniae SHV-5 was reduced from &amp;gt;100 and 160 mg/kg of body weight to 2 and 33.6 mg/kg, respectively, when it was combined with AM-112 at a 1:1 ratio. AM-112 demonstrates potential as a new beta-lactamase inhibitor.&amp;lt;/protect&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|{{TableHeadingColor}} nowrap |&#039;&#039;&#039;Links&#039;&#039;&#039; ||  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=pubmed&amp;amp;dopt=Abstract&amp;amp;list_uids=12709336 PubMed]&amp;lt;br/&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;/protect&amp;gt;&lt;br /&gt;
==Significance {{HelpIcon|Help:Literature}} ==&lt;br /&gt;
{{LitSignificance}}&lt;br /&gt;
&lt;br /&gt;
== Useful Materials and Methods {{HelpIcon|Help:Literature}}==&lt;br /&gt;
{{LitMaterials}}&lt;br /&gt;
&lt;br /&gt;
==Annotations {{HelpIcon|Help:Literature}}==&lt;br /&gt;
&amp;lt;protect&amp;gt;&amp;lt;!--box uid=63ce1649aab8b3180235b0af7618f667.171736.P4bbcffa5b2232--&amp;gt;&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
******************************************************************************************&lt;br /&gt;
* &lt;br /&gt;
*   ** PLEASE DON&#039;T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. ** &lt;br /&gt;
* &lt;br /&gt;
****************************************************************************************** --&amp;gt;&lt;br /&gt;
{|   id=&amp;quot;P4bbcffa5b2232&amp;quot;  class=&amp;quot; tableEdit GO_table_reference&amp;quot;  &lt;br /&gt;
|- {{table heading style}}&lt;br /&gt;
!|Gene product!!Qualifier!!GO ID!!GO term name!!Evidence Code!!with/from!!Aspect!!Notes!!Status&lt;br /&gt;
&lt;br /&gt;
|- class=&amp;quot;tableEdit_footer&amp;quot; &lt;br /&gt;
|&amp;lt;span class=&amp;quot;tableEdit_editLink plainlinks&amp;quot;&amp;gt;[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&amp;amp;id=63ce1649aab8b3180235b0af7618f667.171736.P4bbcffa5b2232&amp;amp;page=171736&amp;amp;pagename={{FULLPAGENAMEE}}&amp;amp;type=0&amp;amp;template=GO_table_reference edit table]&amp;lt;/span&amp;gt; || || || || || || || ||&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;!--box uid=63ce1649aab8b3180235b0af7618f667.171736.P4bbcffa5b2232--&amp;gt;&amp;lt;/protect&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==EcoliWiki Links {{HelpIcon|Help:Literature}} ==&lt;br /&gt;
{{LitLinks}}&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{RefHelp}}&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>165.91.15.120</name></author>
	</entry>
	<entry>
		<id>https://ecoliwiki.org/colipedia/index.php?title=PMID:12709336&amp;diff=1078369</id>
		<title>PMID:12709336</title>
		<link rel="alternate" type="text/html" href="https://ecoliwiki.org/colipedia/index.php?title=PMID:12709336&amp;diff=1078369"/>
		<updated>2010-04-07T21:56:53Z</updated>

		<summary type="html">&lt;p&gt;165.91.15.120: New PMID: Page!&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>165.91.15.120</name></author>
	</entry>
</feed>